Management of Melanoma Patients: Benefit of Intense Follow-Up Schedule Is Not Demonstrated

Journal of Clinical Oncology

Volumn 21, Issue 19, 2003, Pages 3707-

  Autier, Philippe ^a   Coebergh, Jan Willem ^a   Boniol, Mathieu ^a   Doré, Jean François ^a   De Vries, Esther ^a   Eggermont, Alexander M M ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84943010149     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2003.99.112     Document Type: Letter

References (4)

1. Garbe C, Paul A, Kohler-Späth H, et al: Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: Recommendations for an effective follow-up strategy. J Clin Oncol 21:520-529, 2003.
2. Cole P, Morrison AS: Basic issues in population screening for cancer. J Natl Cancer Inst 64:1263-1272, 1980.
3. Feinstein AR. Clinical epidemiology. The architecture of clinical research. W. B. Saunders Cy, Philadelphia, 1985.
4. Balch CM, Soong SJ, Gershenwald JE, et al: Prognostic factors analysis of 17, 600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19:3622-3634, 2001.